1. Home
  2. AIT vs ABVX Comparison

AIT vs ABVX Comparison

Compare AIT & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Industrial Technologies Inc.

AIT

Applied Industrial Technologies Inc.

HOLD

Current Price

$338.26

Market Cap

12.5B

Sector

Industrials

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$116.44

Market Cap

11.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIT
ABVX
Founded
1923
2013
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
11.9B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
AIT
ABVX
Price
$338.26
$116.44
Analyst Decision
Buy
Buy
Analyst Count
5
13
Target Price
$317.50
$131.31
AVG Volume (30 Days)
238.0K
821.7K
Earning Date
04-28-2026
03-23-2026
Dividend Yield
0.69%
N/A
EPS Growth
8.20
N/A
EPS
10.95
N/A
Revenue
$21,485,000.00
N/A
Revenue This Year
$7.79
$52.14
Revenue Next Year
$5.45
$4,132.27
P/E Ratio
$31.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$238.34
$69.81
52 Week High
$374.80
$148.83

Technical Indicators

Market Signals
Indicator
AIT
ABVX
Relative Strength Index (RSI) 45.27 41.41
Support Level $331.42 $107.67
Resistance Level $345.48 $129.00
Average True Range (ATR) 7.85 3.41
MACD -2.67 -0.78
Stochastic Oscillator 12.14 19.23

Price Performance

Historical Comparison
AIT
ABVX

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: